1. Home
  2. GDC vs COEP Comparison

GDC vs COEP Comparison

Compare GDC & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDC
  • COEP
  • Stock Information
  • Founded
  • GDC 2015
  • COEP 2017
  • Country
  • GDC United States
  • COEP United States
  • Employees
  • GDC N/A
  • COEP N/A
  • Industry
  • GDC Steel/Iron Ore
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GDC Industrials
  • COEP Health Care
  • Exchange
  • GDC Nasdaq
  • COEP Nasdaq
  • Market Cap
  • GDC 29.0M
  • COEP 27.4M
  • IPO Year
  • GDC N/A
  • COEP N/A
  • Fundamental
  • Price
  • GDC $3.80
  • COEP $9.47
  • Analyst Decision
  • GDC
  • COEP
  • Analyst Count
  • GDC 0
  • COEP 0
  • Target Price
  • GDC N/A
  • COEP N/A
  • AVG Volume (30 Days)
  • GDC 169.8K
  • COEP 38.0K
  • Earning Date
  • GDC 08-13-2025
  • COEP 08-15-2025
  • Dividend Yield
  • GDC N/A
  • COEP N/A
  • EPS Growth
  • GDC N/A
  • COEP N/A
  • EPS
  • GDC N/A
  • COEP N/A
  • Revenue
  • GDC N/A
  • COEP $62,874.00
  • Revenue This Year
  • GDC N/A
  • COEP N/A
  • Revenue Next Year
  • GDC N/A
  • COEP N/A
  • P/E Ratio
  • GDC N/A
  • COEP N/A
  • Revenue Growth
  • GDC N/A
  • COEP N/A
  • 52 Week Low
  • GDC $1.03
  • COEP $2.31
  • 52 Week High
  • GDC $12.18
  • COEP $13.70
  • Technical
  • Relative Strength Index (RSI)
  • GDC 68.42
  • COEP 62.24
  • Support Level
  • GDC $3.47
  • COEP $7.25
  • Resistance Level
  • GDC $4.00
  • COEP $9.90
  • Average True Range (ATR)
  • GDC 0.34
  • COEP 0.63
  • MACD
  • GDC 0.04
  • COEP 0.26
  • Stochastic Oscillator
  • GDC 88.79
  • COEP 85.62

About GDC GD Culture Group Limited

GD Culture Group Ltd focuses its business on two segments mainly through the Company and two subsidiaries. 1) AI-driven digital human creation and customization; 2) Live streaming and e-commerce. The company has relentlessly been focusing on serving its customers and creating value for them through the continual innovation and optimization of its products and services. For the AI-driven digital human creation and customization sector, the Company uses AI algorithms and software to generate realistic 3D or 2D digital human models. AI algorithms and machine learning models are used to simulate human characteristics, such as facial expressions, body movements, and even speech patterns.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: